COMSAE PHASE 2 EXAM QUESTIONS & ANSWERS 2026-2027 | UPDATED VERIFIED STUDY GU… EXAM
P R O F E S S I O N A L P R A C T I C E M AT E R I A L S
COMSAE Phase 2 Exam
Questions & Answers 2026-2027 |
Updated Verified Study Guide |
Complete Practice Test
(Rationales)
Verified Answers Exam Ready With Rationales
456 QUESTIONS
DOCUMENT OVERVIEW
This document contains 456 verified questions with corresponding correct answers and detailed rationales,
focusing on medical concepts and research studies. It is suitable for comprehensive exam preparation in the
healthcare field. Students can utilize this resource for effective study, review of key concepts, and
certification exam readiness.
CONTENTS
01 Alzheimer's Study Q1–Q4
02 Hypertension Studies Q5–Q10
03 Study Designs Q11–Q17
04 Patient History and Ethics Q18–Q25
05 Clinical Trials and Statistics Q26–Q214
06 Infection and Contagion Q215–Q221
Page 1
, 07 Pediatric Care Q222–Q228
08 Emergency Medicine Q229–Q234
09 Additional Questions Q235–Q456
E XA M Q U EST I O N S
Q1 QUESTION 1 OF 456
What is the primary outcome measure in the Alzheimer's disease study?
CORRECT ANSWER
The classification of a patient as showing progression or no progression of disease as measured by a standard neuropsychological
test of memory.
RATIONALE
Progression in Alzheimer's disease is primarily assessed through standardized neuropsychological testing that evaluates memory
function, providing a clear metric for categorizing patients' cognitive decline or stability. This classification is critical for understanding
disease trajectory and guiding treatment decisions.
Q2 QUESTION 2 OF 456
How many patients showed progression with the experimental drug in the Alzheimer's study?
CORRECT ANSWER
50 patients.
RATIONALE
Data analysis revealed that out of the total participants, 50 patients exhibited clinical deterioration despite receiving the experimental
drug, highlighting its limited efficacy in halting Alzheimer's progression. This outcome underscores the need for ongoing evaluation of
treatment strategies in neurodegenerative disorders.
Q3 QUESTION 3 OF 456
What is the total number of patients in the Alzheimer's study?
CORRECT ANSWER
240 patients.
Page 2
, RATIONALE
Accurate data collection and analysis are critical in clinical research, and the total patient count reflects the study's sample size, which
impacts the reliability and generalizability of findings. A sample of 240 patients ensures adequate power to detect significant effects
and supports robust statistical analysis.
Q4 QUESTION 4 OF 456
What calculation would best determine how many patients need to be treated for one successful outcome in the Alzheimer's
study?
CORRECT ANSWER
[50/(50 + 70)] / [75/(75 + 45)]
RATIONALE
The calculation represents the treatment effectiveness ratio, comparing the probability of a successful outcome in treated versus
untreated groups, thus determining the number needed to treat (NNT) for one additional successful outcome. This metric is critical in
evaluating the impact of interventions in clinical studies.
Q5 QUESTION 5 OF 456
What was the reduction in systolic blood pressure with combination therapy compared to hydrochlorothiazide alone?
CORRECT ANSWER
25 mmHg (95% CI = 15-35 mmHg, p = 0.049).
RATIONALE
A reduction of 25 mmHg in systolic blood pressure indicates a significant therapeutic effect of combination therapy over
hydrochlorothiazide alone, demonstrating enhanced efficacy in hypertension management. The confidence interval and p-value confirm
statistical significance, reinforcing the reliability of the observed outcome.
Q6 QUESTION 6 OF 456
What conclusion can be drawn from the study comparing combination therapy to hydrochlorothiazide alone?
CORRECT ANSWER
There is an approximate 5% probability that the decrease in systolic blood pressure was due to chance.
RATIONALE
A 5% probability indicates that the results are statistically significant, suggesting that the observed decrease in systolic blood pressure
is likely a true effect of combination therapy rather than a random occurrence. This level of significance implies confidence in the
efficacy of the treatment compared to hydrochlorothiazide alone.
Page 3
, Q7 QUESTION 7 OF 456
What is the significance of a p-value of 0.049 in the hypertension study?
CORRECT ANSWER
It indicates that the results are statistically significant, with a less than 5% probability that the results are due to chance.
RATIONALE
049 signifies that the likelihood of observing the results due to random chance is less than 5%, supporting the rejection of the null
hypothesis and indicating statistical significance in the study's findings. This threshold is commonly used to infer that the observed
effects are likely reflective of true differences rather than mere sampling variability.
Q8 QUESTION 8 OF 456
In the study evaluating combination therapy for hypertension, what was the control treatment?
CORRECT ANSWER
Hydrochlorothiazide alone.
RATIONALE
Using hydrochlorothiazide alone as the control treatment establishes a baseline for evaluating the efficacy of combination therapy,
allowing for comparison against standard monotherapy in managing hypertension. This design isolates the effects of the additional
medication, facilitating a clearer understanding of its potential benefits.
Q9 QUESTION 9 OF 456
What is the significance of a 95% confidence interval in clinical studies?
CORRECT ANSWER
It indicates the range within which the true effect size is likely to fall 95% of the time.
RATIONALE
A 95% confidence interval quantifies the uncertainty surrounding an estimate, providing a statistical range that likely contains the
population parameter, thus guiding clinicians in interpreting the reliability and precision of study results. This concept is foundational in
understanding the variability and potential for error in clinical research.
Q10 QUESTION 10 OF 456
Page 4
P R O F E S S I O N A L P R A C T I C E M AT E R I A L S
COMSAE Phase 2 Exam
Questions & Answers 2026-2027 |
Updated Verified Study Guide |
Complete Practice Test
(Rationales)
Verified Answers Exam Ready With Rationales
456 QUESTIONS
DOCUMENT OVERVIEW
This document contains 456 verified questions with corresponding correct answers and detailed rationales,
focusing on medical concepts and research studies. It is suitable for comprehensive exam preparation in the
healthcare field. Students can utilize this resource for effective study, review of key concepts, and
certification exam readiness.
CONTENTS
01 Alzheimer's Study Q1–Q4
02 Hypertension Studies Q5–Q10
03 Study Designs Q11–Q17
04 Patient History and Ethics Q18–Q25
05 Clinical Trials and Statistics Q26–Q214
06 Infection and Contagion Q215–Q221
Page 1
, 07 Pediatric Care Q222–Q228
08 Emergency Medicine Q229–Q234
09 Additional Questions Q235–Q456
E XA M Q U EST I O N S
Q1 QUESTION 1 OF 456
What is the primary outcome measure in the Alzheimer's disease study?
CORRECT ANSWER
The classification of a patient as showing progression or no progression of disease as measured by a standard neuropsychological
test of memory.
RATIONALE
Progression in Alzheimer's disease is primarily assessed through standardized neuropsychological testing that evaluates memory
function, providing a clear metric for categorizing patients' cognitive decline or stability. This classification is critical for understanding
disease trajectory and guiding treatment decisions.
Q2 QUESTION 2 OF 456
How many patients showed progression with the experimental drug in the Alzheimer's study?
CORRECT ANSWER
50 patients.
RATIONALE
Data analysis revealed that out of the total participants, 50 patients exhibited clinical deterioration despite receiving the experimental
drug, highlighting its limited efficacy in halting Alzheimer's progression. This outcome underscores the need for ongoing evaluation of
treatment strategies in neurodegenerative disorders.
Q3 QUESTION 3 OF 456
What is the total number of patients in the Alzheimer's study?
CORRECT ANSWER
240 patients.
Page 2
, RATIONALE
Accurate data collection and analysis are critical in clinical research, and the total patient count reflects the study's sample size, which
impacts the reliability and generalizability of findings. A sample of 240 patients ensures adequate power to detect significant effects
and supports robust statistical analysis.
Q4 QUESTION 4 OF 456
What calculation would best determine how many patients need to be treated for one successful outcome in the Alzheimer's
study?
CORRECT ANSWER
[50/(50 + 70)] / [75/(75 + 45)]
RATIONALE
The calculation represents the treatment effectiveness ratio, comparing the probability of a successful outcome in treated versus
untreated groups, thus determining the number needed to treat (NNT) for one additional successful outcome. This metric is critical in
evaluating the impact of interventions in clinical studies.
Q5 QUESTION 5 OF 456
What was the reduction in systolic blood pressure with combination therapy compared to hydrochlorothiazide alone?
CORRECT ANSWER
25 mmHg (95% CI = 15-35 mmHg, p = 0.049).
RATIONALE
A reduction of 25 mmHg in systolic blood pressure indicates a significant therapeutic effect of combination therapy over
hydrochlorothiazide alone, demonstrating enhanced efficacy in hypertension management. The confidence interval and p-value confirm
statistical significance, reinforcing the reliability of the observed outcome.
Q6 QUESTION 6 OF 456
What conclusion can be drawn from the study comparing combination therapy to hydrochlorothiazide alone?
CORRECT ANSWER
There is an approximate 5% probability that the decrease in systolic blood pressure was due to chance.
RATIONALE
A 5% probability indicates that the results are statistically significant, suggesting that the observed decrease in systolic blood pressure
is likely a true effect of combination therapy rather than a random occurrence. This level of significance implies confidence in the
efficacy of the treatment compared to hydrochlorothiazide alone.
Page 3
, Q7 QUESTION 7 OF 456
What is the significance of a p-value of 0.049 in the hypertension study?
CORRECT ANSWER
It indicates that the results are statistically significant, with a less than 5% probability that the results are due to chance.
RATIONALE
049 signifies that the likelihood of observing the results due to random chance is less than 5%, supporting the rejection of the null
hypothesis and indicating statistical significance in the study's findings. This threshold is commonly used to infer that the observed
effects are likely reflective of true differences rather than mere sampling variability.
Q8 QUESTION 8 OF 456
In the study evaluating combination therapy for hypertension, what was the control treatment?
CORRECT ANSWER
Hydrochlorothiazide alone.
RATIONALE
Using hydrochlorothiazide alone as the control treatment establishes a baseline for evaluating the efficacy of combination therapy,
allowing for comparison against standard monotherapy in managing hypertension. This design isolates the effects of the additional
medication, facilitating a clearer understanding of its potential benefits.
Q9 QUESTION 9 OF 456
What is the significance of a 95% confidence interval in clinical studies?
CORRECT ANSWER
It indicates the range within which the true effect size is likely to fall 95% of the time.
RATIONALE
A 95% confidence interval quantifies the uncertainty surrounding an estimate, providing a statistical range that likely contains the
population parameter, thus guiding clinicians in interpreting the reliability and precision of study results. This concept is foundational in
understanding the variability and potential for error in clinical research.
Q10 QUESTION 10 OF 456
Page 4
